A B S T R A C T A quantitative in vitro assay was employed to directly assess the effect of corticosteroids on the IgG and complement receptor function of human mononuclear phagocytic cells. In this system corticosteroids-were solubilized with cholesterol-phospholipid sonicated dispersions before exposure to mononuclear cells. Solubilized corticosteroids at concentrations between 10-' and 10' M inhibited both IgG and complement receptor activity in a dose-response fashion. Inhibition was dependent upon the time of interaction of the mononuclear cells with corticosteroids and was halfmaximal by 15 min. The inhibitory effect at all concentrations of hydrocortisone was partially overcome by increasing the number of IgG molecules per erythrocyte. Hydrocortisone also inhibited the binding of erythrocytes coated with both IgG and C3, despite the fact that when both were on the erythrocyte surface a synergistic effect on binding to mononuclear cells was observed. At the steroid concentrations employed, the capacity of mononuclear cells to exclude trypan blue and to take up latex particles and neutral red was unaffected. Mineralocorticoids also inhibited receptor activity, but the sex hormones were less effective. These studies demonstrate an effect of steroid hormones on cell membrane receptor function, and they suggest that an inhibition of the recognition system for IgG and C3 in vivo may explain, in part, the effect of corticosteroids in man.
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This work was presented in part at the Annual Meeting of the American Society of Hematology, Atlanta, Ga., December, 1974. Dr. Schreiber is a Leukemia Scholar of the Leukemia INTRODUCTION The macrophage IgG and complement receptors are important in host defense (1, 2) and are responsible for the increased clearance of immunoglobulin-and complement-coated cells in patients with autoimmune hemolytic anemia and autoimmune thrombocytopenia. Corticosteroids are effective in the treatment of IgG-induced autoimmune hemolysis (3, 4) . Existing data suggest that this effect results from a decrease in erythrocyte sensitization with antibody by decreasing antibody production (5, 6) or by decreasing the binding of antibody to the erythrocyte surface (6) .
Previous studies have shown that corticosteroids decrease the clearance of antibody-coated red cells in man (3, 6) and rats (7) and IgG-and/or C3-coated red cells in guinea pigs (8) . In the latter study Atkinson et al. demonstrated that IgG-sensitized erythrocytes were cleared in corticosteroid-treated guinea pigs as if they had fewer IgG molecules per red cell, suggesting a decreased recognition of immunoglobulin-or complement-coated cells by the macrophages of the reticuloendothelial system of the steroid-treated animal. Indeed recent studies have shown that corticosteroids can affect macrophage (9) and monocyte (10) activity. However, none of these studies have shown an effect of corticosteroids on monocyte or macrophage receptor function. To assess this, we employed a quantitative in vitro model derived from that described by LoBuglio et al. (11) , using human erythrocytes and homologous peripheral blood mononuclear phagocytic cells. In order to present poorly soluble steroids in a form which might interact more effectively with the mononuclear cell membrane, we first solubilized corticosteroids with cholesterol-phospholipict sonicated dispersions (12, 13 (16) .
Isolation of rabbit IgG anti-human IgG, anti-human C3, and complement components. 3 ml of rabbit anti-human IgG or rabbit anti-human C3 antiserum was applied to a 5 X 100-cm Sephadex G-200 column equilibrated with 0.0035 M phosphate buffer, pH 7.4, containing 0.15 M NaCl and fractionated by upward flow at 15 ml per h. Each IgG fraction was pooled, concentrated to 20 ml, absorbed three times with D-positive human erythrocytes, and utilized in the quantitative IgG and C3 studies below.
Fresh frozen guinea pig serum was obtained from Rockland, Inc. (Gilbertsville, Pa.). Partially purified guinea pig C2 and human C1 were prepared by a modification of established methods (17, 18) as were cells coated with hemolytic antibody and the fourth component of complement (EAC4) (19) .
Preparation of rabbit IgM anticrythrocyte antiserum.
Erythrocytes obtained from human donors were washed three times in EDTA buffer with removal of the buffy coat and two times with VBS. 1 ml of increasing concentrations of red blood cells (RBC) (1 X 109-3 X 109 RBC) in VBS was injected intravenously 3-4 times per wk over a 3-wk course into the ear vein of New Zealand white rabbits. Bleedings were done 5-10 days after the last injection and 3.5 ml of those antisera with the highest hemagglutinin activity were fractionated by Sephadex G-200 chromatography (5 X 100 cm as above) and the IgM-containing peak pooled so as to contain no detectable IgG by Ouchterlony analysis (20 Preparation of human erythrocytes sensitized with IgM and C3 (EIgMC3). Whole human blood obtained and washed with removal of the buffy coat as above was resuspended to 1 X 108 RBC per ml with EDTA buffer and sensitized at 37'C with an equal volume of IgM antierythrocyte antibody diluted in EDTA buffer, washed once with EDTA buffer, and washed twice with HBSS. 5 X 107 of these RBC were incubated with 1: 16 dilution of fresh autologous serum as a source of C3 at 37'C for 15 min, washed three times with HBSS, and resuspended to 5 X 107 RBC per ml with HBSS. The number of IgM and C3 molecules per EIgMC3 was determined by C1 fixation and transfer (see below).
In all experiments utilizing EIgMC3, control erythrocytes sensitized with IgM alone without exposure to serum, as well as erythrocytes exposed to serum in the absence of IgM antibody, were employed. For experiments examining mononuclear cell binding of EIgMC3, red cells were radiolabeled with ["Cr] sodium dichromate (100 1tCi per ml of whole blood) before sensitization. Erythrocytes sensitized with subagglutinating concentrations of IgM antierythrocyte antibody were not agglutinated when incubated with anti-IgG antiserum. 30 molecules of IgM per RBC, as determined by Cl fixation and transfer (see below), were sufficient to cause detectable direct agglutination.
Quantitation of the number of immunoglobulin or C3 molecules per erythrocyte. The Cl fixation and transfer method was used to determine the average number of IgG molecules per erythrocyte in the sensitized erythrocyte population (22, 15) . This technique provides a minimum estimate of the number of immunoglobulin molecules per cell (22) . D-positive erythrocytes suspended in EDTA buffer were sensitized with twofold falling dilutions of human anti-D antiserum diluted in EDTA buffer as indicated in the preparation of IgG-sensitized erythrocytes. The average number of IgG Cl-fixing sites generated was determined after sensitization with rabbit IgG anti-human IgG and typical dose-response curves with a slope of 1.0 were obtained, directly relating the number of Cl-fixing sites to the number of IgG molecules per erythrocyte (23, 24 The number of IgM molecules per RBC was determined by direct C1 fixation and transfer after sensitization of human erythrocytes suspended in EDTA buffer with twofold falling dilutions of IgM antierythrocyte antibody diluted in EDTA buffer (22, 15) . Typical dose-response curves were obtained with a slope of 1.0. The slope of 1.0 has been taken to indicate that one IgM molecule is capable of fixing one molecule of C1 (23) . In all experiments using IgM antibody, erythrocytes were sensitized with approximately 120 molecules of IgM per RBC.
The number of C3 molecules per EIgMC3 was estimated by determining the number of Cl-fixing sites generated after exposure to 2-mercaptoethanol and IgG anti-C3 (25) . Erythrocytes sensitized with 120 molecules of IgM antibody were incubated with serial twofold falling dilutions of autologous serum as a source of C3 for 15 min at 37'C, washed once with VBS, incubated with 0.05 M 2-mercaptoethanol for 30 min at 37'C, washed twice in EDTA buffer, and incubated with an optimal concentration of anti-C3 (25, 26) before C1 fixation and transfer. Typical dose-response curves with a slope of 1.0 directly relating the number of Cl-fixing sites generated by anti-C3 to the concentration of serum employed wvere obtained. The number of Cl-fixing sites generated by anti-C3 relates to a minimum estimate of the absolute number of C3 molecules per RBC (25, 26) .
In all experiments using EIgMC3, erythrocytes were sensitized with 120 molecules of IgM and a 1: 16 concentration of serum. This concentration of serum generated approximately 2,500 Cl-fixing sites with anti-C3. This method of analysis of cell-bound C3 detects both C3b and its major degradation product, C3d. IgM-sensitized erythrocytes were exposed to autologous serum for 15 min at 37'C; after this incubation period, one would expect most of the cell bound C3 to be in the form C3b (27) . EIgMC3 were immune adherence positive.
Immune adherence assay. Immune adherence assays were performed as previously described (27) . 5 (Fig. 1, D) .
To further assess the effect of HC, monolayers were preincubated with 4 X 10' M and 8 X 10' M HC for varying time intervals (Fig. 2) . No inhibition of IgGcoated erythrocyte binding was observed with up to 5 min of preincubation with 8 X 10' M or up to 15 min of preincubation with 4 X 10' M HC. Thereafter, a progressive inhibition of the capacity of the mononuclear cells to bind IgG-sensitized erythrocytes was observed.
The effect of hydrocortisone concentration on the inhibition of mononuclear cell IgG receptor activity was examined in two ways (Fig. 3) There is evidence that erythrocytes more heavily sensitized with IgG may still be cleared in vivo in corticosteroid-treated animals (8) . Therefore, the effect of the number of IgG molecules per red cell on the ability of HC-treated mononuclear cells to detect IgG-coated erythrocytes was examined. With increasing numbers of IgG molecules per red cell there was a progressive decrease in the inhibitory effect of HC (Fig. 4) . At all concentrations of HC examined (2-8 X 10' M), inhibition was achieved at each level of IgG sensitization in a dose-dependent fashion.
The effect of HC on the mononuclear cell C3 receptor was examined in a similar fashion. When mononuclear cells preincubated with HC were incubated with red cells coated with C3, results similar to those obtained with IgG-coated cells were observed (Fig. 5) . Inhibition was 90% at HC concentrations of 8 X 10' M and approximately half-maximal at 1 X 10-4 M HC. Neither IgMsensitized erythrocytes not incubated with serum nor unsensitized erythrocytes incubated in serum were bound to the monolayers. The average number of red cells bound per mononuclear cell was calculated from the radioactivity (5'Cr) per monolayer
(1 X 106 mononuclear cells).
The capacity of HC to inhibit erythrocytes sensitized with both IgG and C3 was also examined (Table I) . IgG-sensitized erythrocytes were coated with C3 and the binding to monolayers compared to that of erythrocytes sensitized with either C3 or IgG alone. The number of IgG and C3 molecules per erythrocyte was the same whether erythrocytes were sensitized with both IgG and C3 or whether they were sensitized with IgG or C3 alone. Table II . HC did not diminish the number of mononuclear cells per monolayer, nor did it increase the percentage of mononuclear cells capable of excluding trypan blue. The capacity of mononuclear cells to take up neutral red or latex particles was also unaffected. The capacity of other steroid hormones to influence the IgG receptor activity of mononuclear cells was also examined. Monolayers were preincubated with each steroid (300 Lg/ml) solubilized in cholesterol-phospholipid mixtures (Table III) . As with HC, the corticosteroid derivatives prednisone and dexamethasone markedly inhibited the binding of IgG-coated red cells. Mineralocorticoids also caused a marked inhibition of TgG receptor activity, but the sex hormones had a less profound 
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In vitro studies involving steroid hormones are limited by the low solubility of steroids in aqueous solutions. However, steroids may be solubilized by sonication with cholesterol-phospholipid mixtures (12) . Mixtures with a cholesterol: phospholipid molar ratio of 1.0 have been used in our studies, since it is known that this proportion does not affect either the lipid composition or the function of other human peripheral blood cell membranes (29, 30) .
Solubilized hydrocortisone (HC) inhibited mononuclear cell IgG and C3 receptor function in a dose-response fashion (Figs. 3 and 5 ). The effect of HC was directly on the mononuclear cell monolayer, as it was not reversed by washing (Fig. 1) and was dependent upon the time of interaction of HC with the mononuclear cells (Fig. 2) . However, once IgG-coated erythrocytes were bound to their mononuclear cell attachment site, HC did not cause their removal (Fig. 1) .
Mononuclear cells were viable as determined by trypan blue exclusion and at the concentrations of HC examined nonimmune phagocytosis of latex particles and neutral red was unaffected while IgG receptor activity was markedly inhibited (Table II) (38) . In this study we have not distinguished between C3b and C4b, and thus the relative contribution of each in binding erythrocytes to the mononuclear monolayer cells is undetermined.
In our system, as has been previously described (15, 39, 40) , complement is required for the binding of IgMsensitized cells to macrophages, and at the concentration of IgM employed we have confirmed the absence of a receptor for IgM on human peripheral blood monocytes. The clearance of erythrocytes in IgM-induced hemolytic anemia in man (cold agglutinin disease) is dependent upon the macrophage complement receptors (26, 15, 27) . Corticosteroid therapy is not as effective in cold agglutinin disease as in warm antibody (IgG) autoimmune hemolytic anemia (3, 4) . Corticosteroids, however, have been demonstrated to decrease the clearance of IgM-sensitized cells in an animal model (8) . This apparent discrepancy may relate to the large number of C3b molecules per erythrocyte in cold hemagglutin disease or to species differences in the systems involved.
Our data are in keeping with the in vivo clinical (6) and experimental (8) evidence that the improved red blood cell survival with corticosteroids can be overcome when the concentration of IgG per erythrocyte is increased. Increasing the number of IgG molecules per erythrocyte resulted in increased numbers of erythrocytes bound per HC-treated mononuclear cell at all concentrations of HC (Fig. 4) . Furthermore, with increased numbers of IgG per erythrocyte the percentage inhibition observed at each concentration of HC became less marked.
Erythrocytes coated with IgG and complement are cleared more rapidly in vivo than erythrocytes coated with IgG alone (15, 41, 42) , and corticosteroid treatment is less effective in improving the clearance of cells sensitized with both IgG and C3 (8, 41) . This is consistant with our observation that erythrocytes coated with both IgG and C3 bind more effectively to HCtreated mononuclear cells than red cells coated with either IgG or C3 (Table I) .
Mononuclear cell binding of IgG-and C3-coated cells is greater than the additive binding observed with cells coated with either IgG or C3 (Table I ). This suggests a synergistic interaction between the IgG and complement receptors. Mantovani et al. previously showed that complement markedly enhanced the binding of IgG-sensitized cells to mouse peritoneal macrophages (40) . However, they did not examine macrophage binding of complement-coated cells alone. Huber et al. studied the human monocyte IgG and C3 receptors in a heterologous system which employed sheep red blood cells and rabbit IgG antibody. Their studies revealed a cooperative interaction between the monocyte IgG and C3 receptors in phagocytosis (39) .
Although not assessed directly, it appears that the locus of action of steroid hormones in these studies is at the membrane level. While a direct effect of steroid hormones on membranes has been postulated, it has been difficult to establish (43) . A wide range of steroids can be incorporated into natural and artificial lipid membranes (44, 45) ; however, there does not appear to be a constant relationship between the ability of a steroid to do so and the structural features of the steroid molecule. The effect of steroids on membranes has been observed most vividly in their ability to stabilize or labilize artificial lipid membrane vesicles (46, 47) . In addition, some steroid hormones bind to the membrane proteins of red cells and this appears to underlie the effect of progesterone on the storage of human red cells (48) . It is unclear whether the effect which we have observed results from a direct effect on membrane lipids, a direct effect on membrane proteins (e.g., the receptors themselves), or an indirect effect on the membrane exerted from within the cell.
Rinehardt et al. recently examined the effect of corticosteroids in vitro (10) and in vivo (49) on the human peripheral blood monocyte. They observed no inhibition of IgG receptor activity and the complement receptor was not studied. However, their study differs in that monocytes were not preincubated with steroid and they did not employ corticosteroids in a lipid, membrane-soluble form. Additionally, our studies indicate that inhibition of IgG receptor activity is dependent upon the concentration of hydrocortisone as well as the number of IgG molecules per erythrocyte. The concentration of hydrocortisone employed in our studies are similar to plasma steroid levels that have been achieved in vivo (50, 51) . Nonetheless, whether hydrocortisone can directly affect IgG receptor function in vivo remains to be determined.
